Credit Suisse Group started coverage on shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in a report issued on Thursday, November 2nd, Marketbeat reports. The brokerage issued a neutral rating and a $35.00 price target on the stock.
Several other equities research analysts also recently issued reports on the stock. Mizuho restated a neutral rating on shares of Acadia Healthcare in a research note on Monday, October 30th. BMO Capital Markets lowered their price objective on shares of Acadia Healthcare from $52.00 to $48.00 and set an outperform rating on the stock in a research note on Thursday, October 26th. Craig Hallum restated a buy rating and issued a $41.00 price objective (down previously from $65.00) on shares of Acadia Healthcare in a research note on Thursday, October 26th. Jefferies Group LLC set a $42.00 price objective on shares of Acadia Healthcare and gave the stock a buy rating in a research note on Wednesday, October 25th. Finally, Citigroup Inc. lowered their price objective on shares of Acadia Healthcare from $61.00 to $44.00 and set a buy rating on the stock in a research note on Wednesday, October 25th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company. Acadia Healthcare presently has a consensus rating of Hold and an average price target of $45.15.
Acadia Healthcare (NASDAQ:ACHC) traded up $0.80 during trading hours on Thursday, hitting $29.81. 1,166,337 shares of the stock were exchanged, compared to its average volume of 1,352,302. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $54.34. The company has a market capitalization of $2,620.00, a price-to-earnings ratio of 13.03, a price-to-earnings-growth ratio of 1.11 and a beta of 0.89. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.36 and a current ratio of 1.36.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 EPS for the quarter, missing the Zacks’ consensus estimate of $0.65 by ($0.07). The firm had revenue of $716.70 million during the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The company’s revenue for the quarter was down 2.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.58 EPS. research analysts expect that Acadia Healthcare will post 2.23 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This story was originally posted by BBNS and is the sole property of of BBNS. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://baseballnewssource.com/markets/credit-suisse-group-begins-coverage-on-acadia-healthcare-company-inc-achc/1751334.html.
Several large investors have recently modified their holdings of the company. Arthur Zaske & Associates LLC acquired a new stake in shares of Acadia Healthcare in the 3rd quarter valued at $283,000. Neuberger Berman Group LLC boosted its stake in shares of Acadia Healthcare by 5.1% in the 3rd quarter. Neuberger Berman Group LLC now owns 879,951 shares of the company’s stock valued at $42,026,000 after purchasing an additional 42,713 shares in the last quarter. Granahan Investment Management Inc. MA boosted its stake in shares of Acadia Healthcare by 11.6% in the 3rd quarter. Granahan Investment Management Inc. MA now owns 69,011 shares of the company’s stock valued at $3,296,000 after purchasing an additional 7,186 shares in the last quarter. Jane Street Group LLC acquired a new stake in shares of Acadia Healthcare in the 3rd quarter valued at $316,000. Finally, Envestnet Asset Management Inc. boosted its stake in shares of Acadia Healthcare by 266.9% in the 3rd quarter. Envestnet Asset Management Inc. now owns 80,684 shares of the company’s stock valued at $3,855,000 after purchasing an additional 58,692 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with our FREE daily email newsletter.